Latest filing published 04 Mar 2026 for ENDRA Life Sciences Inc..
No signal scores available.
Richard Jacroux appears in our data through filings on ENDRA Life Sciences Inc. shares, published by SEC (Form 4). Between 21 January 2026 and 2 March 2026, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 4 March 2026: a share grant, in ENDRA Life Sciences Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations